SEC Form 4 · accession 0000899243-18-015718
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Terrence Gibbs
Officer — General Counsel
Period of report
Feb 9, 2018
Accepted (ET)
Jun 8, 2018 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2018 | S | 2,202 | $4.28 | D | 16,911 | D | |
| Common Stock | Jun 6, 2018 | A | 14,499 | $0.00 | A | 31,410 | D | |
| Common Stock | Jun 6, 2018 | F | 4,705 | $8.53 | D | 26,705 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,849 shares acquired under the Issuer's employee stock purchase plan between November 15, 2017 and May 15, 2018, and 5,833 shares acquired on February 9, 2018, upon vesting and conversion on a one-to-one basis of restricted stock units granted to the reporting person on February 9, 2017.